MedFirst Healthcare Services, Inc (4175) Fair Value & Analysis
Healthcare · TW · Market cap 2.3B TWD
Fair value as of: Jun 24, 2026
Analysis
MedFirst Healthcare Services, Inc (4175) currently trades at 53.70 TWD, while our model-based Fair Value estimate is 77.17 TWD — implying the stock looks roughly 43.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
MedFirst Healthcare Services, Inc. engages in the sale of medical supplies in Taiwan and China. The company offers diabetes care products, respiratory treatment, incontinence and wound dressing, medical devices, ostomy care, pain relief products, supplements, and rehabilitation products, as well as homecare, childcare, and maternal products. The company also provides beauty care and oral hygiene products, daily essentials, medical books, cosmetics, and functional food and beverages, as well as wellness food and drugs. In addition, it offers fresh goods, home appliances, pre-orders, linen laundry services, and rental services, as well as prescription drug services. Further, the company is involved in the trade of medical supplies; sale of water electrolysis machine; foreign medical supplies; laundry products; brand agent distribution; and management of shopping malls. It sells products through its retail stores and online. MedFirst Healthcare Services, Inc. was founded in 1990 and is…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is MedFirst Healthcare Services, Inc (4175) undervalued?
What is the fair value of 4175?
What is the quality score of 4175?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.